A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
0.003% AR-15512 ophthalmic solution
OTHER:
Artificial Tears
Sponsor
Alcon Research